Opposite effects of cGMP-dependent protein kinase on cGMP production by soluble and particular...

1
BioMed Central Page 1 of 1 (page number not for citation purposes) BMC Pharmacology Open Access Poster presentation Opposite effects of cGMP-dependent protein kinase on cGMP production by soluble and particular guanylyl cyclase in adult ventricular myocytes Liliana Castro* and Rodolphe Fischmeister Address: INSERM-U769, Faculty of Pharmacy, Chatenay Malabry, France Email: Rodolphe Fischmeister - [email protected] * Corresponding author Background Both particulate (pGC) and soluble guanylyl cyclases (sGC) synthesize cGMP. While sGC is activated by nitric oxide (NO), pGC is activated by natriuretic peptides (NPs) such as ANP or BNP. Physiological effects of cGMP are mainly mediated by cGMP-dependent protein kinase (PKG) and cGMP phosphodiesterases (PDEs), namely PDE2 and PDE5. We hypothesised that PKG may underlie regulatory feedback in cGMP signals produced by pGC and sGC activation in adult rat ventricular myocytes (ARVMs). Materials and methods To test this hypothesis, subsarcolemmal cGMP signals elicited by NO-donors or NPs in the presence of the PKG inhibitor, KT5823 (KT, 50 nM) were monitored in ARVMs. Myocytes were infected by an adenovirus express- ing the WT rat olfactory cyclic nucleotide-gated channel CNGA2 and the cGMP-gated current (I CNG ) was recorded by the whole-cell patch-clamp technique. Results Application of the membrane permeant cGMP analog Sp- 8-pCPT-cGMPS (Sp-8, 100 μM) induced a large I CNG cur- rent in myocytes infected by CNGA2 adenovirus, but not in control cells. KT increased 3-fold the I CNG current fol- lowed by activation of sGC by S-nitroso-N-acetyl-peni- cillamine (SNAP, 100 μM). This effect was abolished in the presence of the non selective PDE inhibitor IBMX (100 μM) or a selective PDE5 inhibitor (sildenafil, 100 nM). Surprisingly, KT decreased (by 50%) the I CNG current stimulated by ANP (10 nM and 100 nM) in a PDE-inde- pendent manner, but had no effect on total cGMP content measured by radioimmunoassay, which is controlled by PDE2 and PDE5 subtypes. Conclusion Our results suggest that in ARVMs the subsarcolemmal cGMP pools generated by sGC or pGC are differentially regulated by PKG. In the sGC pool, PDE5 mediates the effects of PKG, while in the pGC pool, the PKG effect is independent of PDE activity. These differential regula- tions of cGMP signals may underlie the specific effects of NPs and NO-donors on cardiac function. from 3 rd International Conference on cGMP Generators, Effectors and Therapeutic Implications Dresden, Germany. 15–17 June 2007 Published: 25 July 2007 BMC Pharmacology 2007, 7(Suppl 1):P10 doi:10.1186/1471-2210-7-S1-P10 <supplement> <title> <p>3<sup>rd </sup>International Conference on cGMP Generators, Effectors and Therapeutic Implications</p> </title> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1471-2210-7-S1-full.pdf">here</a>.</note> </supplement> This abstract is available from: http://www.biomedcentral.com/1471-2210/7/S1/P10 © 2007 Castro and Fischmeister; licensee BioMed Central Ltd.

Transcript of Opposite effects of cGMP-dependent protein kinase on cGMP production by soluble and particular...

Page 1: Opposite effects of cGMP-dependent protein kinase on cGMP production by soluble and particular guanylyl cyclase in adult ventricular myocytes

BioMed Central

Page 1 of 1(page number not for citation purposes)

BMC Pharmacology

Open AccessPoster presentationOpposite effects of cGMP-dependent protein kinase on cGMP production by soluble and particular guanylyl cyclase in adult ventricular myocytesLiliana Castro* and Rodolphe Fischmeister

Address: INSERM-U769, Faculty of Pharmacy, Chatenay Malabry, France

Email: Rodolphe Fischmeister - [email protected]

* Corresponding author

BackgroundBoth particulate (pGC) and soluble guanylyl cyclases(sGC) synthesize cGMP. While sGC is activated by nitricoxide (NO), pGC is activated by natriuretic peptides(NPs) such as ANP or BNP. Physiological effects of cGMPare mainly mediated by cGMP-dependent protein kinase(PKG) and cGMP phosphodiesterases (PDEs), namelyPDE2 and PDE5. We hypothesised that PKG may underlieregulatory feedback in cGMP signals produced by pGCand sGC activation in adult rat ventricular myocytes(ARVMs).

Materials and methodsTo test this hypothesis, subsarcolemmal cGMP signalselicited by NO-donors or NPs in the presence of the PKGinhibitor, KT5823 (KT, 50 nM) were monitored inARVMs. Myocytes were infected by an adenovirus express-ing the WT rat olfactory cyclic nucleotide-gated channelCNGA2 and the cGMP-gated current (ICNG) was recordedby the whole-cell patch-clamp technique.

ResultsApplication of the membrane permeant cGMP analog Sp-8-pCPT-cGMPS (Sp-8, 100 μM) induced a large ICNG cur-rent in myocytes infected by CNGA2 adenovirus, but notin control cells. KT increased 3-fold the ICNG current fol-lowed by activation of sGC by S-nitroso-N-acetyl-peni-cillamine (SNAP, 100 μM). This effect was abolished inthe presence of the non selective PDE inhibitor IBMX

(100 μM) or a selective PDE5 inhibitor (sildenafil, 100nM). Surprisingly, KT decreased (by 50%) the ICNG currentstimulated by ANP (10 nM and 100 nM) in a PDE-inde-pendent manner, but had no effect on total cGMP contentmeasured by radioimmunoassay, which is controlled byPDE2 and PDE5 subtypes.

ConclusionOur results suggest that in ARVMs the subsarcolemmalcGMP pools generated by sGC or pGC are differentiallyregulated by PKG. In the sGC pool, PDE5 mediates theeffects of PKG, while in the pGC pool, the PKG effect isindependent of PDE activity. These differential regula-tions of cGMP signals may underlie the specific effects ofNPs and NO-donors on cardiac function.

from 3rd International Conference on cGMP Generators, Effectors and Therapeutic ImplicationsDresden, Germany. 15–17 June 2007

Published: 25 July 2007

BMC Pharmacology 2007, 7(Suppl 1):P10 doi:10.1186/1471-2210-7-S1-P10

<supplement> <title> <p>3<sup>rd </sup>International Conference on cGMP Generators, Effectors and Therapeutic Implications</p> </title> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1471-2210-7-S1-full.pdf">here</a>.</note> </supplement>

This abstract is available from: http://www.biomedcentral.com/1471-2210/7/S1/P10

© 2007 Castro and Fischmeister; licensee BioMed Central Ltd.